Compare · BMGL vs OPCH
BMGL vs OPCH
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.40B, about 375.2x BMGL ($9.1M).
- Over the past year, BMGL is down 80.7% and OPCH is down 27.2% - OPCH leads by 53.4 points.
- OPCH has been more active in the news (4 items in the past 4 weeks vs 3 for BMGL).
- OPCH has more recent analyst coverage (16 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Option Care Health Inc.
- Price
- $5.19-16.29%
- $21.66+2.82%
- Market cap
- $9.1M
- $3.40B
- 1M return
- -25.05%
- -1.57%
- 1Y return
- -80.69%
- -27.24%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 3
- 4
- Recent ratings
- 0
- 16
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest BMGL
- SEC Form 3 filed by new insider Neo Alton Chun How
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL to Effect Reverse Share Split on June 22, 2026
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
Latest OPCH
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)